Tekmira to Webcast Presentation at 15th Annual BIO CEO & Investor Conference

Tekmira to Webcast Presentation at 15th Annual BIO CEO & Investor Conference

VANCOUVER, British Columbia, Feb. 6, 2013 (GLOBE NEWSWIRE) -- Tekmira
Pharmaceuticals Corporation (Nasdaq:TKMR) (TSX:TKM), a leading developer of
RNA interference (RNAi) therapeutics, today announced that management will
present a company overview at the 15^th Annual BIO CEO & Investor Conference
on Tuesday, February 12, 2013 at 10:30 am ET (7:30 am PT) at the Waldorf
Astoria Hotel in New York, NY.

A live webcast of the presentation can be accessed through the Investor
section of Tekmira's website at www.tekmirapharm.com. An archived webcast will
be available on the Tekmira website for 90 days following the event.

About Tekmira

Tekmira Pharmaceuticals Corporation is a biopharmaceutical company focused on
advancing novel RNAi therapeutics and providing its leading lipid nanoparticle
delivery technology to pharmaceutical partners. Tekmira has been working in
the field of nucleic acid delivery for over a decade and has broad
intellectual property covering LNPs. Further information about Tekmira can be
found at www.tekmirapharm.com. Tekmira is based in Vancouver, B.C.

The Tekmira Pharmaceuticals logo is available at
http://www.globenewswire.com/newsroom/prs/?pkgid=8319

CONTACT: Investors
         Jodi Regts
         Director, Investor Relations
         Phone: 604-419-3234
         Email: jregts@tekmirapharm.com
        
         Media
         David Ryan
         Longview Communications Inc.
         Phone: 416-649-8007
         Email: dryan@longviewcomms.ca

Tekmira Pharmaceuticals Logo
 
Press spacebar to pause and continue. Press esc to stop.